Reddys, Biocon, Cipla, and Sun Pharma, developing GLP-1 generics (Reuters, 2024), face: Bioequivalence Hurdles: Peptides like semaglutide require advanced analytics for CDSCO compliance (Biosimilar Guidelines, 2016), with impurities risking immunogenicity (ResearchGate, 2023)
Available in brand-name and compounded forms, semaglutide supports GLP-1 activity and is widely used for weight management
What to keep in mind: Compounded medications use the same active ingredients as brand-name drugs but are not FDA-approved finished products
There should be more tolerance of the fact that you can be very healthy at a range of weights, Dushay says
A) Our program includes FDA-approved and off-label medication options that may include GLP-1, GIP, or combination GLP-1/GIP therapies
Boosting GLP-1 by natural products